Jeanette Leusen, PhDProfessor Antibody Therapy at University Medical Center UtrechtSpeaker
Profile
Jeanette Leusen received her PhD in 1995 at the University of Amsterdam (UvA), The Netherlands, and is now Professor AntibodyTherapy leading a group of 24 FTE within the Center for Translational Immunology of the University Medical Center Utrecht. In the last 25 years Prof Leusen investigated FcR biology and the potential of IgA as a therapeutic antibody. She has co-authored over 150 peer-reviewed papers and is inventor on 13 patents concerning antibody therapy. Since 2012 she is also head of the UMAB facility for antibody generation, and in 2018 she founded the spin-off company TigaTx, that is dedicated to proceed with engineered IgA towards the clinic.
Agenda Sessions
Targeting the High Affinity Receptor for IgG (FcγRI) for Auto-Immune disease
, 08:50View SessionCo-Chairs’ Remarks
, 14:20View Session